Nirmatrelvir/ritonavir is manufactured by Pfizer and is used to treat Covid-19. ## Compulsory licenses A compulsory licence application is currently pending for Nirmatrelvir/ritonavir in Chile. The application was submitted by civil society. A compulsory licence application is currently pending for Nirmatrelvir/ritonavir in Peru. The application was submitted by Civil society. A compulsory licence application is currently pending for Nirmatrelvir/ritonavir in Colombia. The application was submitted by civil society. ## Other products issued by the same manufacturer [[Nirmatrelvir/ritonavir]] [[Sunitinib]] ## Other products for the same disease [[Remdesivir]] [[Favipiravir]] [[Covid-19 vaccine (mRNA based)]]